Wang Xianlei, Zhao Xuelei, Huang Lihui, Wen Cheng, Wang Xueyao, Cheng Xiaohua
Department of Otolaryngology Head and Neck Surgery,Beijing Tongren Hospital,Capital Medical University,Beijing Institute of Otolaryngology,Key Laboratory of Otolaryngology Head and Neck Surgery,Capital Medical University,Ministry of Education,Beijing,100005,China.
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2020 Feb;34(2):113-118. doi: 10.13201/j.issn.1001-1781.2020.02.004.
The aim of this study is to explore the genotype and hearing phenotype of deaf infants with mutation of gene. Subjects were 121 infants with gene mutations who were treated in the Children's Hearing Diagnosis Center of Beijing Tongren hospital. All subjects were accepted to undertake the universal newborns hearing screening(UNHS) and series of objective audiometry, including auditory brainstem response, distortion product otoacoustic emission, auditory steady-state response and other audiological tests. All subjects were screened for nine pathogenic variants in four genes or all exons of the gene, and then were diagnosed as infants with gene mutations. Initially, analyzing their genotypes and hearing phenotypes generally. Then, the subjects were divided into two groups according to the genotypes: T/T group(truncated/truncated mutations, 89 cases) and T/NT group(truncated/non-truncated mutations, 32 cases). Chi-square test was used to analyze the results of UNHS, hearing degree, audiogram patterns and symmetry/asymmetry of binaural hearing phenotype. Eventually, analyzing the results of UNHS. The most common truncated mutation was c.235delC(64.88%, 157/242) and the most common non-truncated mutation was c.109G>A(11.16%, 27/242). The homozygous mutation of c.235delC/c.235delC was the dominant in T/T group(38.84%, 47/121), and the compound heterozygous mutation of c.235delC/c.109G>A was the dominant in T/NT group(18.18%, 22/121). 81.82%(99/121) of subjects failed in UNHS, including 74.38%(90/121) with bilateral reference, 7.44%(9/121) with a single pass. The refer rate of UNHS of group T/T and T/NT were 86.52%(77/89) and 68.75%, respectively. There was a statistically significant difference between the two groups(<0.05). 85.95%(104/121) of subjects were diagnosed as hearing loss and 14.05%(17/121) of subjects were diagnosed as normal hearing. The degree of hearing loss: profound, severe, moderate and mild were 31.40%(38/121), 19.01%(23/121), 24.79%(30/121) and 10.74%(13/121), respectively. There was no subjects with normal hearing in T/T group and individuals with severe and profound hearing loss accounted for the highest proportion(65.17%, 58/89), while in T/NT group, normal hearing accounted for 53.13%(17/32) and mild and moderate hearing loss accounted for the highest proportion(37.5%, 12/32). There was statistically significant difference between the two groups(<0.05). Of 104 patients(208 ears) with hearing loss, the audiogram patterns: flat, descending, ascending, residual, Valley and other types were 49.03%(102/208), 12.02%(25/208), 8.65%(18/208), 7.69%(16/204), 3.36%(7/204) and 19.23%(40/204), respectively. The two most common types in T/T group were flat(47.19%, 84/178) and other types(20.22%, 36/178), while in T/NT group were flat(60.00%, 18/30) and ascending(20.00%, 6/30). There was statistically significant difference between the two groups(<0.05). There were 50 cases(48.07%) with symmetrical hearing phenotype and 54 cases(51.93%) with asymmetrical hearing phenotype. Asymmetry was predominant in T/T group(53.93%, 48/89), and symmetry was predominant in T/NT group(60.00%, 9/15). There was no statistically significant difference between the two groups(>0.05). In this study, c.235delC/c.235delC homozygous mutation was dominant in T/T group and c.235delC/c.109G>A heterozygous mutation was dominant in T/NT Group. The hearing phenotypes in T/T group were mostly bilateral asymmetric severe hearing loss, and those in T/NT Group were bilateral symmetric mild to moderate hearing loss, special attention should be paid to the audiological characteristics of different genotypes.
本研究旨在探讨基因发生突变的聋儿的基因型与听力表型。研究对象为在北京同仁医院儿童听力诊断中心接受治疗的121例基因发生突变的婴儿。所有研究对象均接受了新生儿听力普遍筛查(UNHS)及一系列客观听力测试,包括听性脑干反应、畸变产物耳声发射、听觉稳态反应及其他听力学检查。对所有研究对象进行了四个基因或该基因所有外显子的九个致病变异的筛查,随后被诊断为基因发生突变的婴儿。首先,总体分析他们的基因型和听力表型。然后,根据基因型将研究对象分为两组:T/T组(截短/截短突变,89例)和T/NT组(截短/非截短突变,32例)。采用卡方检验分析UNHS结果、听力程度、听力图类型以及双耳听力表型的对称性/不对称性。最后,分析UNHS结果。最常见的截短突变是c.235delC(64.88%,157/242),最常见的非截短突变是c.109G>A(11.16%,27/242)。c.235delC/c.235delC纯合突变在T/T组中占主导地位(38.84%,47/121),c.235delC/c.109G>A复合杂合突变在T/NT组中占主导地位(18.18%,22/121)。81.82%(99/121)的研究对象UNHS未通过,其中双侧未通过的占74.38%(90/121),单侧通过的占7.44%(9/121)。T/T组和T/NT组的UNHS通过率分别为86.52%(77/89)和68.75%。两组之间存在统计学显著差异(<0.05)。85.95%(104/121)的研究对象被诊断为听力损失,14.05%(17/121)的研究对象被诊断为听力正常。听力损失程度:极重度、重度、中度和轻度分别为31.40%(-38/121)、19.01%(23/121)、24.79%(30/121)和10.74%(13/121)。T/T组中无听力正常的研究对象,重度和极重度听力损失个体占比最高(65.17%,58/89),而在T/NT组中,听力正常占53.13%(17/32),轻度和中度听力损失占比最高(37.5%,12/32)。两组之间存在统计学显著差异(<0.05)。在104例(208耳)听力损失患者中,听力图类型:平坦型、下降型、上升型、残留型、低谷型及其他类型分别为49.03%(102/208)、12.02%(25/208)、8.65%(18/208)、7.69%(16/204)、3.36%(7/204)和19.23%(40/204)。T/T组中最常见的两种类型是平坦型(47.19%,84/178)和其他类型(20.22%,36/178),而在T/NT组中是平坦型(60.00%,18/30)和上升型(20.00%,6/30)。两组之间存在统计学显著差异(<0.05)。有50例(48.07%)听力表型对称,54例(51.93%)听力表型不对称。T/T组中不对称占主导(53.93%,48/89),T/NT组中对称占主导(60.00%,9/15)。两组之间无统计学显著差异(>0.05)。在本研究中,c.235delC/c.235delC纯合突变在T/T组中占主导地位,c.235delC/c.109G>A杂合突变在T/NT组中占主导地位。T/T组的听力表型大多为双侧不对称重度听力损失,T/NT组的听力表型为双侧对称轻度至中度听力损失,应特别关注不同基因型的听力学特征。